← Back to overview

DGX Quest Diagnostics Incorporated

Health Care Services · $227.86 -0.02%
Price Alert:
Price & Volume
RSI (14)
MACD (12, 26, 9)

Compare

Shows % change over the period so different-priced stocks can be compared fairly.

Technical Indicators

RSI (14)
67.4
Relative Strength Index (RSI): measures how fast and how much the price has moved recently, on a 0-100 scale. Above 70 is often called "overbought" (may be due for a pause or pullback); below 30 is "oversold" (may be due for a bounce). It is not a guarantee either way.
SMA 20 / 50 / 200
201.31 / 192.37 / 158.15
Moving Averages (SMA): the average closing price over the last N days, smoothing out day-to-day noise. When price trades above its moving averages, and shorter averages are above longer ones, it is generally read as a healthier trend.
MACD / Signal
8.13 / 5.35
MACD: compares two moving averages (12-day and 26-day) to gauge momentum. When the MACD line crosses above its signal line, momentum is turning up; crossing below suggests momentum turning down.

Fundamentals

P/E
24.2
Price-to-Earnings ratio: how many dollars investors pay for $1 of the company's annual profit. Higher usually means the market expects faster growth (or the stock is expensive); lower can mean it's cheap — or that growth is expected to slow.
Market Cap
25.15B
Market Capitalization: the total value of all the company's shares — share price × number of shares. A rough measure of company size.
Div Yield
1.51%
Dividend Yield: the annual cash dividend paid to shareholders, as a percentage of the current share price.
52-Week Range
165.78 – 237.78
52-Week Range: the lowest and highest price the stock has traded at over the last year. Where the price sits in this range hints at recent strength or weakness.

Trend Analysis

Quest Diagnostics Incorporated is trading at $227.86, -0.02% versus the previous close. The price is near its 52-week high — the top of its recent trading range.
RSI is in a neutral range — no strong overbought/oversold signal.
The 50-day average is above the 200-day average ("golden cross" territory) — a commonly watched bullish signal.
MACD is above its signal line — momentum currently leans positive.
Combine this reading with the fundamentals below before forming a view — no single indicator is a guarantee of what happens next.

Latest News

Why Quest Diagnostics (DGX) Is Up 8.2% After Raising 2026 Guidance And Boosting Buybacks
Simply Wall St. · 2026-07-26 04:17
Quest Diagnostics (DGX) Stock Gets Fair Value Boost After Q2 Beat And Higher Guidance
Simply Wall St. · 2026-07-26 00:16
Are You Looking for a Top Momentum Pick? Why Quest Diagnostics (DGX) is a Great Choice
Zacks · 2026-07-24 16:00
Mizuho Securities Adjusts Quest Diagnostics Price Target to $260 From $235, Maintains Outperform Rating
MT Newswires · 2026-07-24 13:22
Baird Adjusts Quest Diagnostics Price Target to $255 From $236, Maintains Neutral Rating
MT Newswires · 2026-07-24 13:21
Barclays Raises Quest Diagnostics Price Target to $250 From $230, Maintains Overweight Rating
MT Newswires · 2026-07-24 13:21
UBS Adjusts Price Target on Quest Diagnostics to $232 From $220, Maintains Neutral Rating
MT Newswires · 2026-07-24 13:21
Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out?
Zacks · 2026-07-24 13:15
Educational information only. Nothing here is investment advice — always do your own research and consider talking to a licensed financial advisor before buying or selling.
Data: Yahoo Finance, refreshed periodically and cached locally.